---
schema_version: "secwatch.filing_event.v1"
accession: "0001607062-22-000733"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2022-11-22T23:59:59+00:00"
generated_at: "2026-06-21T14:03:47.147751+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nutex Health reports Q3 net loss of $422.5M and $100M Lincoln Park equity facility

## Summary
- Q3 net revenue $28.4M, down ~76% YoY, including $29M reduction in accounts receivable estimate.
- Net loss attributable to Nutex $422.5M in Q3, driven by $408.5M non-cash goodwill impairment.
- Adjusted EBITDA loss of $15.7M in Q3; positive $18.5M for nine months ended September 30, 2022.
- Net cash from operations $46.1M for nine months; cash and equivalents $36.6M as of Sep 30.
- Entered $100M common stock purchase agreement with Lincoln Park Capital over 36 months, no warrants.

## SEC filing metadata
- accession: 0001607062-22-000733
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2022-11-22T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000160706222000733/0001607062-22-000733-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000160706222000733/nutx111422form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001607062-22-000733
- JSON: https://secwatch.observer/filing/0001607062-22-000733.json
- Plain text: https://secwatch.observer/filing/0001607062-22-000733.txt

## Key facts
- Earnings Releases
  Nutex Health Inc. reported Three months ended September 30, 2022 results: revenue $28.4 million, net income $(422.5) million.
  - Period: Three months ended September 30, 2022
  - Revenue: $28.4 million
  - Net income: $(422.5) million
  - Result: reported results
  source text: Financial Highlights for the Three Months Ended September 30, 2022 (Unaudited): • Net revenue of $28.4 million. In the three months ended September 30, 2022, we reduced our estimate of the ultimate amounts of accounts receivable we will collect for prior periods. This change in estimate reduced revenue for the three months ended September 30, 2022 by approximately $29 million. • Net income attributable to Nutex Health of $(422.5) million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000160706222000733/0001607062-22-000733-index.htm
- Earnings Releases
  Nutex Health Inc. reported Nine months ended September 30, 2022 results: revenue $165.6 million, net income $(420.4) million.
  - Period: Nine months ended September 30, 2022
  - Revenue: $165.6 million
  - Net income: $(420.4) million
  - Result: reported results
  source text: Financial Highlights for the Nine Months Ended September 30, 2022 (Unaudited): • Net revenue of $165.6 million. • Net income attributable to Nutex Health of $(420.4) million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000160706222000733/0001607062-22-000733-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.